Choroidal neovascularization secondary to half-dose photodynamic therapy for chronic central serous chorioretinopathy: A case report

RATIONALE: Half-dose or reduced-fluence photodynamic therapy (PDT) with verteporfin has been well acknowledged to be the most effective and permanent treatment with very low rates of complications. However, we report a case of chronic central serous chorioretinopathy (CSC) who developed choroidal ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhengwei, Bao, Xiaona, Wu, Zhifeng, Zhang, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899877/
https://www.ncbi.nlm.nih.gov/pubmed/33607835
http://dx.doi.org/10.1097/MD.0000000000024790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899877/
https://www.ncbi.nlm.nih.gov/pubmed/33607835
http://dx.doi.org/10.1097/MD.0000000000024790

Ejemplares similares